Form 4: Hims & Hers CLO Sells Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


Hims & Hers Health, Inc.'s Chief Legal Officer, Soleil Boughton, sold 2,631 shares of Class A Common Stock for $35.22 per share under a pre-arranged trading plan.

Summary

  • Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., reported a transaction involving the company's Class A Common Stock.
  • On November 24, 2025, 2,631 shares of Class A Common Stock were disposed of at a price of $35.22 per share.
  • The sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by the reporting person on August 28, 2024.
  • Following this transaction, Soleil Boughton beneficially owns 153,225 shares of Class A Common Stock directly.

Sentiment

Score: 5

Explanation: The transaction is a planned sale under a Rule 10b5-1 trading plan, which is generally considered a neutral event. It reflects an executive's pre-scheduled liquidity or diversification strategy rather than a direct signal of positive or negative company performance or outlook.

Positives

  • NA

Negatives

  • NA

Risks

  • NA

Future Outlook

NA

Industry Context

This insider transaction is a routine disclosure and does not inherently reflect broader industry trends or competitive dynamics. It represents a planned liquidity event for an executive rather than a strategic move related to the company's market position or industry performance.

Stakeholder Impact

  • Shareholders may note the reduction in direct ownership by a key executive, though the pre-arranged nature of the sale under a 10b5-1 plan typically mitigates concerns about immediate negative sentiment.

Key Dates

DateDescription
08/28/2024Date the Rule 10b5-1 trading plan was adopted by Soleil Boughton.
11/24/2025Date of the reported transaction (sale of Class A Common Stock).
11/25/2025Date the Form 4 was signed by the Attorney-in-Fact for Soleil Boughton.

Recommendation

hold

The sale by the Chief Legal Officer was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned liquidity event rather than a reaction to new material information. This type of transaction is generally considered neutral and does not typically warrant a change in investment recommendation based solely on this filing.

Keywords

Hims & Hers Health, HIMS, Soleil Boughton, Chief Legal Officer, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Equity Transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.